Company news
Solvonis Therapeutics PLC news in 2024
Solvonis Therapeutics PLC's news releases, calls and decks from 2024, newest first.
Proactive Investors Interview with CEO and Chair
December 18, 2024
Proposed acquisition of Awakn Life Sciences Corp
December 16, 2024
Initial Results University of Nottingham
December 11, 2024
Notice of GM and proposed name change
December 3, 2024
Research Agreement
October 15, 2024
Research and development update
October 4, 2024
Non Regulatory-Interview with Dennis Purcell
September 26, 2024
Commercial Collaboration Progress Update
August 28, 2024
Directorate Change
August 12, 2024
Non Regulatory Appnt of Senior Scientific Advisor
July 30, 2024
Commercial Collaboration
July 23, 2024
Patent Filings
July 11, 2024
Admission & Director/PDMR Shareholding
July 10, 2024
Result of AGM
June 28, 2024
Business Update
June 7, 2024
Notice of AGM
June 4, 2024
Patent Application
May 31, 2024
Regulatory Application
May 28, 2024
Update on recent developments
May 9, 2024
Grant of Haemostatic Hydrogel Patent
May 7, 2024
Divestment of Graft Polymer d.o.o – Slo facility
May 3, 2024
Replacement of Chief Executive Officer
May 2, 2024
Annual Financial Report
April 30, 2024
Loan facility update
April 23, 2024
Chairman & Directorate Change & Financial Update
March 15, 2024
GM Statement
January 8, 2024